Hoylecohen LLC raised its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,830 shares of the biopharmaceutical company’s stock after acquiring an additional 327 shares during the period. […]